In addition, XN has been shown to have the ability to reduce ROS, the bearing of which develops in AP, through the activation of Nrf2 (Nuclear factor erythroid 2-related factor 2), which consists largely in the transition from the cytosol to the cell nucleus. The gene discussed is NFE2L2; the disease is alkaline phosphatase measurement.